Corrigendum to “WCN24-786 PHASE I DOSE ESCALATION STUDY OF SHR6508, A CALCIUM-SENSING RECEPTOR AGONIST, IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Pages S368-S369]
Saved in:
| Main Authors: | Zhiming Ye, Li Fan, Rui Yan, Bicheng Liu, Linghui Zhou, Guangqun Xing, Wei Zhao, Zunsong Wang, Deguang Wang, Min Zhang, Xin Zhang, Xinyu Yang, Xue Yang, Xueqing Yu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-08-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924017649 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
WCN24-786 PHASE I DOSE ESCALATION STUDY OF SHR6508, A CALCIUM-SENSING RECEPTOR AGONIST, IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
by: Zhiming Ye, et al.
Published: (2024-04-01) -
Optevoz (Isère). Les Verchères, 369, rue Philippe Tassier
by: Catherine Coquidé
Published: (2013-12-01) -
Corrigendum to “Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV” [Kidney International Reports Volume 7, Issue 4, April 2022, Pages 786-796]
by: Rachel K.Y. Hung, et al.
Published: (2024-12-01) -
Metformin inhibits migration and invasion of renal carcinoma cell line 786-O by regulating acetylation of histone
by: HE De-jiao, et al.
Published: (2019-01-01) -
The study of antiproliferative and apoptosis-promoting effect of cinobufotalin on kidney cancer cells 786-O
by: WANG Ming-qi, et al.
Published: (2019-01-01)